-+ 0.00%
-+ 0.00%
-+ 0.00%

Gain Therapeutics Q3 EPS $(0.15) Beats $(0.16) Estimate

Benzinga·11/12/2025 12:14:45
Listen to the news
Gain Therapeutics (NASDAQ:GANX) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.16) by 7.41 percent. This is a 11.76 percent increase over losses of $(0.17) per share from the same period last year.